1.
Gammazza AM, Campanella C, Barone R, Caruso Bavisotto C, Gorska M, Wozniak M, Carini F, Cappello F, D’Anneo A, Lauricella M, Zummo G, Conway De Macario E, Macario AJ, Di Felice V. Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60/p53 complex dissociation and instauration of replicative senescence. Ital J Anat Embryol [Internet]. 2017 Oct. 6 [cited 2024 Jun. 17];121(1):131. Available from: https://oajournals.fupress.net/index.php/ijae/article/view/2269